BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15920554)

  • 1. Fatty acid synthase expression in cutaneous melanocytic neoplasms.
    Kapur P; Rakheja D; Roy LC; Hoang MP
    Mod Pathol; 2005 Aug; 18(8):1107-12. PubMed ID: 15920554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spitz nevi and atypical Spitz nevi/tumors: a histologic and immunohistochemical analysis.
    Kapur P; Selim MA; Roy LC; Yegappan M; Weinberg AG; Hoang MP
    Mod Pathol; 2005 Feb; 18(2):197-204. PubMed ID: 15467715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions.
    Zembowicz A; Knoepp SM; Bei T; Stergiopoulos S; Eng C; Mihm MC; Stratakis CA
    Am J Surg Pathol; 2007 Nov; 31(11):1764-75. PubMed ID: 18059235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. hTERT expression in melanocytic lesions: an immunohistochemical study on paraffin-embedded tissue.
    Fullen DR; Zhu W; Thomas D; Su LD
    J Cutan Pathol; 2005 Nov; 32(10):680-4. PubMed ID: 16293180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of fatty acid synthase (FASN) in oral nevi and melanoma.
    de Andrade BA; León JE; Carlos R; Delgado-Azañero W; Mosqueda-Taylor A; Graner E; de Almeida OP
    Oral Dis; 2011 Nov; 17(8):808-12. PubMed ID: 21819495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cdc7 expression in melanomas, Spitz tumors and melanocytic nevi.
    Clarke LE; Fountaine TJ; Hennessy J; Bruggeman RD; Clarke JT; Mauger DT; Helm KF
    J Cutan Pathol; 2009 Apr; 36(4):433-8. PubMed ID: 19278428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human telomerase RNA component expression in Spitz nevi, common melanocytic nevi, and malignant melanomas.
    Guttman-Yassky E; Bergman R; Manov L; Sprecher E; Shaefer Y; Kerner H
    J Cutan Pathol; 2002 Jul; 29(6):341-6. PubMed ID: 12135464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p16 expression: a marker of differentiation between childhood malignant melanomas and Spitz nevi.
    Al Dhaybi R; Agoumi M; Gagné I; McCuaig C; Powell J; Kokta V
    J Am Acad Dermatol; 2011 Aug; 65(2):357-363. PubMed ID: 21550132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
    Nasr MR; El-Zammar O
    Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
    Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M
    J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical expression of cyclooxygenase-2 (COX-2) in oral nevi and melanoma.
    de Souza do Nascimento J; Carlos R; Delgado-Azañero W; Mosqueda Taylor A; de Almeida OP; Romañach MJ; de Andrade BA
    J Oral Pathol Med; 2016 Jul; 45(6):440-3. PubMed ID: 26608958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of p16 expression and copy number changes of CDKN2A in a spectrum of spitzoid melanocytic lesions.
    Harms PW; Hocker TL; Zhao L; Chan MP; Andea AA; Wang M; Harms KL; Wang ML; Carskadon S; Palanisamy N; Fullen DR
    Hum Pathol; 2016 Dec; 58():152-160. PubMed ID: 27569296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential diagnostic utility of PRAME and p16 immunohistochemistry in melanocytic nevi and malignant melanoma.
    Bahmad HF; Oh KS; Alexis J
    J Cutan Pathol; 2023 Aug; 50(8):763-772. PubMed ID: 37114299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S100A6 protein expression is different in Spitz nevi and melanomas.
    Ribé A; McNutt NS
    Mod Pathol; 2003 May; 16(5):505-11. PubMed ID: 12748257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inducible nitric oxide synthase expression in melanoma: implications in lymphangiogenesis.
    Massi D; De Nisi MC; Franchi A; Mourmouras V; Baroni G; Panelos J; Santucci M; Miracco C
    Mod Pathol; 2009 Jan; 22(1):21-30. PubMed ID: 18660796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of activated Akt in benign nevi, Spitz nevi and melanomas.
    Kantrow SM; Boyd AS; Ellis DL; Nanney LB; Richmond A; Shyr Y; Robbins JB
    J Cutan Pathol; 2007 Aug; 34(8):593-6. PubMed ID: 17640227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin D1 overexpression in Spitz nevi: an immunohistochemical study.
    Nagasaka T; Lai R; Medeiros LJ; Brynes RK; McCourty A; Harada T; Saddik M
    Am J Dermatopathol; 1999 Apr; 21(2):115-20. PubMed ID: 10218669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Spitz nevus and Reed nevus: simulating melanoma in adults].
    Paredes B; Hardmeier T
    Pathologe; 1998 Nov; 19(6):403-11. PubMed ID: 9885003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRAF and NRAS mutations in spitzoid melanocytic lesions.
    Fullen DR; Poynter JN; Lowe L; Su LD; Elder JT; Nair RP; Johnson TM; Gruber SB
    Mod Pathol; 2006 Oct; 19(10):1324-32. PubMed ID: 16799476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation between Spitz nevi and malignant melanomas by interphase fluorescence in situ hybridization.
    Wettengel GV; Draeger J; Kiesewetter F; Schell H; Neubauer S; Gebhart E
    Int J Oncol; 1999 Jun; 14(6):1177-83. PubMed ID: 10339676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.